Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 27.94
-0.03 (-0.11%)
At close: Feb 12, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 215.97 million as of February 13, 2026. Its market cap has increased by 65.56% in one year.
Market Cap
215.97M
Enterprise Value
234.91M
Revenue
44.14M
Ranking
n/a
PE Ratio
19.64
Stock Price
27.94
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 215.97M, an increase of 566.61%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 215.97M | 8.10% |
| Dec 31, 2025 | 199.80M | 111.40% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smruthi Organics | 1.32B |
| Krebs Biochemicals & Industries | 1.30B |
| Accretion Nutraveda | 1.22B |
| Resonance Specialties | 1.14B |
| Bacil Pharma | 600.82M |
| Vasundhara Rasayans | 431.44M |
| Supha Pharmachem | 362.88M |
| Crestchem | 281.58M |